Many people using GLP-1 receptor agonists like semaglutide experience a gradual increase in dosage to optimize weight loss results. Typically, a patient might start on a low dose and increase it over 12 to 24 weeks, as the body adapts and tolerates the medication. For example, reaching a 10mg dose after 12 weeks is considered a significant milestone and is often seen as a sign of treatment progression. Over approximately 24 weeks or more, doses may be adjusted further based on effectiveness and side effects. Semaglutide is notable for its role in appetite regulation and blood sugar control, making it a dual-purpose drug commonly prescribed for both weight management and type 2 diabetes. Patients report varying experiences during their weight loss journeys, with some achieving notable results through consistent use combined with lifestyle changes like diet and exercise. It is important for users to follow medical guidance strictly during their GLP-1 regimen, ensuring that each dosage adjustment is safe and suitable for their individual health condition. Support communities and forums can provide valuable peer insights and encouragement, offering real-life context to treatment timelines and outcomes. If you are considering or currently undergoing GLP-1 therapy, staying informed about dosage schedules and expected progress helps set realistic goals and fosters patience throughout your weight loss journey.